Catalysts for Novo Nordisk Inc
40 tracked
Oct 19, 2018
approval
SAXENDA (LIRAGLUTIDE) — FDA approval
Novo Nordisk Inc
→
Dec 12, 2017
approval
XULTOPHY 100/3.6 (INSULIN DEGLUDEC) — FDA approval
Novo Nordisk Inc
→
May 22, 2017
approval
SAXENDA (LIRAGLUTIDE) — FDA approval
Novo Nordisk Inc
→
Apr 26, 2017
approval
SAXENDA (LIRAGLUTIDE) — FDA approval
Novo Nordisk Inc
→
Apr 26, 2017
approval
SAXENDA (LIRAGLUTIDE) — FDA approval
Novo Nordisk Inc
→
Nov 21, 2016
approval
XULTOPHY 100/3.6 (INSULIN DEGLUDEC) — FDA approval
Novo Nordisk Inc
→
Sep 22, 2016
approval
SAXENDA (LIRAGLUTIDE) — FDA approval
Novo Nordisk Inc
→
Feb 1, 2016
approval
SAXENDA (LIRAGLUTIDE) — FDA approval
Novo Nordisk Inc
→
Mar 27, 2015
approval
SAXENDA (LIRAGLUTIDE) — FDA approval
Novo Nordisk Inc
→
Dec 23, 2014
approval
SAXENDA (LIRAGLUTIDE) — FDA approval
Novo Nordisk Inc
→